Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Enrolling by invitation × Doxorubicin × 1 year × Clear all

Phase

Status

Active not recruiting 103 Recruiting 97 Completed 52 Not yet recruiting 16 Terminated 9 Suspended 6 Withdrawn 1 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, T-Cell, Peripheral 1

Interventions

Interviews as Topic 6 Educational Status 6 Standard of Care 4 Specimen Handling 4 Surveys and Questionnaires 3 Observation 3 Methods 3 Fluorouracil 3 Fluorodeoxyglucose F18 3 Early Intervention, Educational 3 Dexamethasone 3 Chemoradiotherapy 3 Blood Specimen Collection 3 Biopsy 3 130-nm albumin-bound paclitaxel 3 lenvatinib 2 durvalumab 2 camrelizumab 2 Transcutaneous Electric Nerve Stimulation 2 Temozolomide 2 Surgical Procedures, Operative 2 Radiotherapy 2 Practice Guidelines as Topic 2 Patient Navigation 2 Oxaliplatin 2 Nivolumab 2 Leucovorin 2 Letrozole 2 Health Promotion 2 Genetic Testing 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07258680 2025-12-02

BrEto-TCL

N.N. Petrov National Medical Research Center of Oncology

Phase 3 Enrolling by invitation

Lymphoma, T-Cell, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon ⚡